Barclays PLC Takes $311,000 Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Barclays PLC acquired a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 18,500 shares of the company’s stock, valued at approximately $311,000.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Stephens Inc. AR acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $189,000. Point72 DIFC Ltd acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $573,000. Royce & Associates LP acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $1,260,000. Foundry Partners LLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $1,680,000. Finally, Seven Grand Managers LLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $2,515,000.

Analysts Set New Price Targets

GRDN has been the topic of several recent research reports. Raymond James initiated coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They set an “outperform” rating and a $21.00 price target on the stock. Truist Financial boosted their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Finally, Stephens initiated coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price objective on the stock.

Guardian Pharmacy Services Trading Up 0.7 %

GRDN stock opened at $20.53 on Monday. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $25.74. The business’s 50 day simple moving average is $22.18.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($2.19). The business had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. On average, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insider Activity

In related news, Director Steven D. Cosler acquired 7,000 shares of the stock in a transaction that occurred on Tuesday, November 19th. The stock was purchased at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the purchase, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.